Suppr超能文献

辐射防护剂WR-2721对大鼠操作性行为的影响。

Effect of the radioprotector WR-2721 on operant behavior in the rat.

作者信息

Liu W F, Shih J H, Lee J D, Ma C, Lee S F, Lin C H

机构信息

Fourth Research Department, CSIST, Taiwan, R.O.C.

出版信息

Neurotoxicol Teratol. 1989 May-Jun;11(3):199-204. doi: 10.1016/0892-0362(89)90059-7.

Abstract

The effect of WR-2721 on performance maintained by a fixed-ratio 20 (FR-20) schedule for water reinforcement was studied in male Sprague-Dawley rats. Graded doses of WR-2721 (range 25-100 mg/kg) were administered IP immediately prior to a 60 min test session. WR-2721 had a dose dependent monotonic disruptive effect on FR responding, with significant effects at doses of 50, 75 and 100 mg/kg. WR-2721 also decreased postsession water consumption, but only one significant effect at the highest dose (100 mg/kg). Both slopes of the dose-response regression line are parallel in effect. These data indicate that WR-2721 may affect drinking motivation, which could disrupt operant performance, and WR-2721 affects motor behavior at lower doses than those that depress "motivation" to drink. The log dose-probit analysis on the all-or-none disruptive pattern of pause of responding observed from cumulative records disclosed that the slope of this regression line (s = 1.11) was also almost identical to that of reinforcer decrement analyzed from graded dose-response relationship (s = 1.14) and shared the same estimated ED50's (58.5 and 55.6 mg/kg, respectively). A preliminary study using a variety of pharmacological interventions was also carried out to ascertain if the general functional gastrointestinal disorders produced by WR-2721 may subserve the behavioral deficits. Subcutaneous pretreatments with various selective, peripherally active, gastroprotective drugs [cimetidine (30 and 60 mg/kg), pirenzepine (5 and 10 mg/kg) and domperidone (1, 5 and 10 mg/kg)] 30 min prior to challenge with WR-2721 at dose of 100 mg/kg, demonstrated that these drugs did not yield any apparent significant attenuative effects.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在雄性斯普拉格-道利大鼠中,研究了WR-2721对由固定比率20(FR-20)水强化程序维持的行为表现的影响。在60分钟测试时段之前,立即腹腔注射分级剂量的WR-2721(范围为25-100毫克/千克)。WR-2721对FR反应有剂量依赖性的单调干扰作用,在50、75和100毫克/千克剂量时有显著影响。WR-2721还减少了测试时段后的饮水量,但仅在最高剂量(100毫克/千克)时有显著影响。剂量-反应回归线的两个斜率在效应上是平行的。这些数据表明,WR-2721可能会影响饮水动机,这可能会干扰操作性行为表现,并且WR-2721在比抑制饮水“动机”更低的剂量下就会影响运动行为。对从累积记录中观察到的反应暂停的全或无干扰模式进行的对数剂量-概率分析表明,该回归线的斜率(s = 1.11)也几乎与从分级剂量-反应关系分析的强化物减量的斜率(s = 1.14)相同,并且共享相同的估计ED50(分别为58.5和55.6毫克/千克)。还进行了一项使用多种药理学干预措施的初步研究,以确定WR-2721产生的一般功能性胃肠疾病是否可能导致行为缺陷。在以100毫克/千克剂量用WR-2721进行挑战前30分钟,用各种选择性、外周活性、胃保护药物[西咪替丁(30和60毫克/千克)、哌仑西平(5和10毫克/千克)和多潘立酮(1、5和10毫克/千克)]进行皮下预处理,结果表明这些药物没有产生任何明显的显著减弱作用。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验